Home > Products > ECG Stress Testing in Clinical Trials

ECG Stress Testing in Clinical Trials

Company : Biomedical Systems

UMDC Code : 105010

The value of ECG stress testing (ETT) in clinical trials lies in its ability to detect and assess the degree of coronary disease indentifying possible cardiovascular risk and evaluating treatment response. Patients with coronary artery blockage may produce normal ECGs at rest; however, when the heart is exposed to exercise, significant disease symptoms such as chest discomfort or shortness of breath can be revealed as characteristic abnormalities on the ECG recording. The ECG complex most representative of coronary artery disease is ST segment depression, an indicator of low blood flow to the heart muscle.

Product URL : http://www.biomedsys.com/cardiac-safety-in-clinica
l-trials.html

Last Updated : 11/09/2012

Please provide the following information and a representative of Biomedical Systems will contact you to assist with any questions you might have.